In addition to TP53 and KDM6A mutations [13], which are commonly identified in ESCC, PTPRD mutations and FGFR1 amplification, which are considered poor prognostic factors for ESCC, have also been identified [14, 15]. This evidence concerns the gene PTPRD and esophageal squamous cell carcinoma.